ReachMD

Episodes 1-15 of 15

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Edward B. Garon, MD, MS

    Peer

  1

  

  RestartResume

  Keeping Pace in Lung Cancer – All About Antiangiogenics and TKIs: Current Roles and Future Directions in EGFR-Mutant NSCLC

  Keeping Pace in Lung Cancer – All About Antiangiogenics and TKIs: Current Roles and Future Directions in EGFR-Mutant NSCLC

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    John V. Heymach, MD, PhD

    Peer

  0

  

  RestartResume

  Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC

  Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC

  0.25 credits

• • 

    

    Jay Raman, MD, FACS

    Peer

  • 

    

    Oguz Akin, MD

    Peer

  • 

    

    Robert J. Motzer, MD

    Peer

  • 

    

    Elizabeth Plimack, MD, MS

    Peer

  0

  

  RestartResume

  RCC Treatment Strategies in a Favorable-Risk Patient

  RCC Treatment Strategies in a Favorable-Risk Patient

  0.50 credits

• • 

    

    Jay Raman, MD, FACS

    Peer

  • 

    

    Oguz Akin, MD

    Peer

  • 

    

    Robert J. Motzer, MD

    Peer

  • 

    

    Elizabeth Plimack, MD, MS

    Peer

  1

  

  RestartResume

  RCC Treatment Strategies in a Poor-Risk Patient

  RCC Treatment Strategies in a Poor-Risk Patient

  0.50 credits

• • 

    

    Paul P. Doghramji, MD, FAAFP

    Peer

  • 

    

    Nina Delaney Wagner-Johnston, MD

    Peer

  • 

    

    Seema A. Bhat, MD

    Peer

  2

  

  RestartResume

  The Evolving Landscape of Chronic Lymphocytic Leukemia: Selecting and Managing Targeted Therapy

  The Evolving Landscape of Chronic Lymphocytic Leukemia: Selecting and Managing Targeted Therapy

  0.50 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Anna-Barbara Moscicki, MD

    Peer

  16

  

  RestartResume

  Riding the Wave of Change in Cervical Cancer Screening: Managing Patients in Light of Risk Using Extended Genotyping

  Riding the Wave of Change in Cervical Cancer Screening: Managing Patients in Light of Risk Using Extended Genotyping

  0.25 credits

• • 

    

    Javier Cortes, MD, PhD

    Peer

  • 

    

    Sara A. Hurvitz, MD, FACP

    Peer

  2

  

  RestartResume

  How ADCs Are Transforming HER2+ Metastatic Breast Cancer: Discover the Latest Clinical Trend

  How ADCs Are Transforming HER2+ Metastatic Breast Cancer: Discover the Latest Clinical Trend

  0.25 credits

• • 

    

    Loretta J. Nastoupil, MD

    Peer

  • 

    

    John P. Leonard, MD

    Peer

  4

  

  RestartResume

  Applying Data to Patient Care: Case Review in Follicular Lymphoma

  Applying Data to Patient Care: Case Review in Follicular Lymphoma

  0.25 credits

• • 

    

    Loretta J. Nastoupil, MD

    Peer

  • 

    

    Gilles Salles, MD

    Peer

  6

  

  RestartResume

  Critical Review of Data in Follicular Lymphoma

  Critical Review of Data in Follicular Lymphoma

  0.25 credits

• • 

    

    Loretta J. Nastoupil, MD

    Peer

  • 

    

    Matthew J. Matasar, MD

    Peer

  5

  

  RestartResume

  Creating Personalized Care in Relapsed/Refractory Follicular Lymphoma

  Creating Personalized Care in Relapsed/Refractory Follicular Lymphoma

  0.25 credits

• • 

    

    Richard T. Penson, MD, MRCP

    Peer

  • 

    

    Ana Oaknin, MD

    Peer

  3

  

  RestartResume

  Keeping Pace in Women’s Cancer: Clinical Considerations for Endometrial Cancer—Global Perspectives

  Keeping Pace in Women’s Cancer: Clinical Considerations for Endometrial Cancer—Global Perspectives

  0.25 credits

• • 

    

    Jennifer W. Carlisle, MD

    Peer

  • 

    

    Suresh S. Ramalingam, MD

    Peer

  7

  

  RestartResume

  An Evolving Clinical Landscape in HER2+ and HER2-Mutant Metastatic NSCLC: Critical Updates for Your Practice

  An Evolving Clinical Landscape in HER2+ and HER2-Mutant Metastatic NSCLC: Critical Updates for Your Practice

  0.50 credits

• • 

    

    Paul P. Doghramji, MD, FAAFP

    Peer

  • 

    

    Corey S. Cutler, MD, MPH, FRCPC

    Peer

  • 

    

    Doris M. Ponce, MD

    Peer

  7

  

  RestartResume

  Breakthroughs and Innovations: Managing Complex Cases in Graft-versus-Host Disease

  Breakthroughs and Innovations: Managing Complex Cases in Graft-versus-Host Disease

  0.50 credits

• • 

    

    Chrysalyne D. Schmults, MD, MSCE (Chair)

    Peer

  • 

    

    Omid Hamid, MD

    Peer

  • 

    

    Anokhi Jambusaria, MD, MSCE, FAAD

    Peer

  11

  

  RestartResume

  Selecting the RIGHT Patient for Systemic Therapy in cSCC: A Care Team Forum

  Selecting the RIGHT Patient for Systemic Therapy in cSCC: A Care Team Forum

• • 

    

    Chrysalyne D. Schmults, MD, MSCE (Chair)

    Peer

  • 

    

    Omid Hamid, MD

    Peer

  • 

    

    Anokhi Jambusaria, MD, MSCE, FAAD

    Peer

  11

  

  RestartResume

  New Systemic Options for Managing cSCC: A Care Team Forum

  New Systemic Options for Managing cSCC: A Care Team Forum